Tahithromos’s Abundia Global Impact Group AGIG Stock Holding History

Tahithromos’s Portfolio AGIG Stock Details AGIG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-3,847	Closed	-$221K	–	40
2014 Q2	$221K	Hold	3,847	–	–	0.05%	39
2014 Q1	$265K	Hold	3,847	–	–	0.06%	37
2013 Q4	$120K	Hold	3,847	–	–	0.03%	36
2013 Q3	$139K	Hold	3,847	–	–	0.02%	64
2013 Q2	$130K	Buy	+3,847	New	+$122K	0.02%	55

Other funds holding AGIG

BCA

Benchmark Capital Advisors New York $101M AUM 0.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return

Tahithromos's AGIG Position: Q3 2014 in Review

Tahithromos sold out of Abundia Global Impact Group (AGIG) in Q3 2014, closing a stake of 3,847 shares — an estimated $221K sold.

Tahithromos first reported a position in AGIG in Q2 2013 and held it in 5 quarters. The position peaked at $265K in Q1 2014. 26 funds tracked by Wall St. Rank hold AGIG as of Q3 2014.

Tahithromos reported no remaining Abundia Global Impact Group position as of Q3 2014 after selling out during the quarter.
Tahithromos sold 3,847 Abundia Global Impact Group shares in Q3 2014, an estimated $221K.
Tahithromos first reported a position in Abundia Global Impact Group in Q2 2013 and held it in 5 quarters.
Tahithromos's Abundia Global Impact Group position peaked at $265K in Q1 2014.
26 funds tracked by Wall St. Rank held Abundia Global Impact Group as of Q3 2014.

Based on Tahithromos's 13F filing for Q3 2014, filed 24 Oct 2014.